Ki67 is still considered a useful and reliable marker associated with prognosis, but some studies had mixed results associating high Ki67 expression with the DLBCL outcome and some showed an inverse relationship between the Ki67 index and clinical outcomes [8-11]. Here, MKI67 is linked to diffuse large B-cell lymphoma.